Imagen de Portada
Código QR

Addressing Cell Therapy Challenges Through a Modular, Closed, and Automated Manufacturing System: Scaling cell therapy production workflows requires the establishment of closed, automated steps.

Publicado en:BioPharm International Vol. 36; no. 6; pp. 26 - 30
Autor principal: ZYNDA, EVAN
Formato: pictorial tables/charts Journal Article
Publicado: MJH Life Sciences Jun2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164173065&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 164173065
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Jun2023
      vid: 36
      iid: 6
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        164173065
        164173065
        164173065
        164173065
      ppf: 26
      ppct: 4
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Addressing Cell Therapy Challenges Through a Modular, Closed, and Automated Manufacturing System: Scaling cell therapy production workflows requires the establishment of closed, automated steps.
      aug:
        au: ZYNDA, EVAN
      sug:
        subj:
          Cell Therapy
          Automation
          Workflow
          T Lymphocytes
          Cell Biology
          Autografts
          Treatment Outcomes
          Diffusion of Innovation
          Technology, Medical
          Human Error
          Microbial Contamination
          Cell Separation
      pubtype: Trade Publication
      doctype:
        pictorial
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N